WEDELL-WEDELLSBORG JOHAN purchased 2.9% of their position (127.55K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $890.4K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/11/2023ACC: 0001104659-23-125054
Director10% Owner
Since Sep 2018
+127.55K
Net shares
Net buyer
$890.4K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
127.55K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+6.18K
Price / share
$6.50
Trade value
$40.19K
% of position
0.1%
12/7/2023
4.43M→4.43M
Common Stock
Indirect
Shares
+18.50K
Price / share
$6.99
Trade value
$129.38K
% of position
0.4%
12/8/2023
4.43M→4.45M
Common Stock
Indirect
Shares
+102.86K
Price / share
$7.01
Trade value
$720.84K
% of position
2.3%
12/11/2023
4.45M→4.55M
Total
Net shares
+127.55K
Net value
$890.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/7/2023 | P · Purchase | +6.18K | $6.50 | $40.19K | 0.1% | 4.43M | 4.43M |
| Common Stock Indirect | 12/8/2023 | P · Purchase | +18.50K | $6.99 | $129.38K | 0.4% | 4.43M | 4.45M |
| Common Stock Indirect | 12/11/2023 | P · Purchase | +102.86K | $7.01 | $720.84K | 2.3% | 4.45M | 4.55M |
| Total | +127.55K | $890.41K | ||||||
Derivative Transactions0
No derivative transactions reported